Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,800 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
Diabetes, 2015Protein Biomarkers for Insulin Resistance and Type 2 Diabetes Risk in Two Large Community Cohorts
Nowak C., Sundström J., Gustafsson S. et al.
Olink Target 96
Stroke, 2015Fibroblast Growth Factor 23 and Incidence of Subarachnoid Hemorrhage
Söderholm M., Engström G.
Journal of Pain Research, 2015Evaluation of the protein biomarkers and the analgesic response to systemic methylene blue in patients with refractory neuropathic pain: a double-blind, controlled study
Miclescu A., Svahn M., Gordh T.
Cytokine, 2015The body mass index (BMI) is significantly correlated with levels of cytokines and chemokines in cerebrospinal fluid
Larsson A., Carlsson L., Lind A. et al.
Atherosclerosis, 2015Use of a proximity extension assay proteomics chip to discover new biomarkers for human atherosclerosis
Lind L., Ärnlöv J., Lindahl B. et al.
Journal of Immunological Methods, 2015The effects of age and gender on plasma levels of 63 cytokines
Larsson A., Carlsson L., Gordh T. et al.
Clinical Cancer Research, 2015Head-to-Head Comparison and Evaluation of 92 Plasma Protein Biomarkers for Early Detection of Colorectal Cancer in a True Screening Setting
Chen H., Zucknick M., Werner S. et al.
Biomolecular Detection and Quantification, 2015Proximity assays for sensitive quantification of proteins
Greenwood C., Ruff D., Kirvell S. et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2015Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes
Goncalves I., Bengtsson E., Colhoun H. et al.
Clinical Proteomics, 2015A novel multiplexed immunoassay identifies CEA, IL-8 and prolactin as prospective markers for Dukes’ stages A-D colorectal cancers
Mahboob S., Ahn S., Cheruku H. et al.
PLOS ONE, 2015Low Elastin Content of Carotid Plaques Is Associated with Increased Risk of Ipsilateral Stroke
Asciutto G., Dias N., Edsfeldt A. et al.
Molecular Cancer Therapeutics, 2015The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce Myeloid Suppressor Cells and Release Effector Lymphocyte Responses
Christiansson L., Söderlund S., Mangsbo S. et al.
Frontiers in Neurology, 2014Cerebral Microdialysis for Protein Biomarker Monitoring in the Neurointensive Care Setting – A Technical Approach
Hillered L., Dahlin A., Clausen F. et al.
Arteriosclerosis, Thrombosis, and Vascular Biology, 2014High Plasma Levels of Heparin-Binding Epidermal Growth Factor Are Associated With a More Stable Plaque Phenotype and Reduced Incidence of Coronary Events
Rattik S., Wigren M., Björkbacka H. et al.
Brain, Behavior, and Immunity, 2014Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment
Isgren A., Jakobsson J., Pålsson E. et al.
International Orthopaedics, 2014Exogenous BMP7 corrects plasma iron overload and bone loss in Bmp6-/- mice
Pauk M., Grgurevic L., Brkljacic J. et al.
Nature Communications, 2014Strong effects of genetic and lifestyle factors on biomarker variation and use of personalized cutoffs
Enroth S., Johansson ?., Enroth S. et al.
PLoS ONE, 2014Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability
Assarsson E., Lundberg M., Holmquist G. et al.
PROTEOMICS, 2014Antibody‐based proteomics and biomarker research—Current status and limitations
Solier C., Langen H.
3899 publications
Items per page
3881-3899 of 3899 publications